insights_auto
Why is ORX down 3,34%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,45 SEK
arrow_downward
-3,34%(-0,050) 1D
4-ноя., 17:29:47 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,51 SEK
High
1,65 SEK
Low
1,30 SEK
Mkt. cap
50,80 млн
Avg. vol.
280,57 миң
Volume
801,10 миң
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,51 SEK
High
1,65 SEK
Low
1,30 SEK
Mkt. cap
50,80 млн
Avg. vol.
280,57 миң
Volume
801,10 миң
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
The Japan News
·
42 мүнөт мурун
Stocks Surge, and the Dow Soars 1,500 Points as Oil Prices Tumble Following the US Midterm Elections
Yahoo Finance Singapore
·
1 саат мурун
Has VNET Group (NasdaqGS:VNET) Fallen Far Enough on Sales?
Kalkine
·
45 мүнөт мурун
Can Harmony Biosciences(NASDAQ:HRMY) Hit $1 Billion in WAKIX Revenue for 2026?
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteorexo.com